Mylan Pharmaceuticals Inc.

WV · United States · Reporting entity ID 100000005572

Total reported 2019–2025

$26.9M

#262 of 2,960 reporting companies — 0% of all reported industry payments

$414K in general payments across 16,623 records, plus $26.5M in research funding across 364 records.

How it breaks down

General payments $413,589

Research funding $26,487,237

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.